Kevin J Appelbaum - Net Worth and Insider Trading

Kevin J Appelbaum Net Worth

The estimated net worth of Kevin J Appelbaum is at least $241 dollars as of 2024-11-05. Kevin J Appelbaum is the CEO, 10% Owner of Better Therapeutics Inc and owns about 2,410,469 shares of Better Therapeutics Inc (BTTX) stock worth over $241. Details can be seen in Kevin J Appelbaum's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kevin J Appelbaum has not made any transactions after 2021-12-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Kevin J Appelbaum

To

Kevin J Appelbaum Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kevin J Appelbaum owns 2 companies in total, including Better Therapeutics Inc (BTTX) , and Mountain Crest Acquisition Corp II (MCADU) .

Click here to see the complete history of Kevin J Appelbaum’s form 4 insider trades.

Insider Ownership Summary of Kevin J Appelbaum

Ticker Comapny Transaction Date Type of Owner
BTTX Better Therapeutics Inc 2021-12-20 director & 10 percent owner & Chief Executive Officer
MCADU Mountain Crest Acquisition Corp II 2021-10-28 director & 10 percent owner & Chief Executive Officer

Kevin J Appelbaum Latest Holdings Summary

Kevin J Appelbaum currently owns a total of 1 stock. Kevin J Appelbaum owns 2,410,469 shares of Better Therapeutics Inc (BTTX) as of December 20, 2021, with a value of $241.

Latest Holdings of Kevin J Appelbaum

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BTTX Better Therapeutics Inc 2021-12-20 2,410,469 0.00 241

Holding Weightings of Kevin J Appelbaum


Kevin J Appelbaum Form 4 Trading Tracker

According to the SEC Form 4 filings, Kevin J Appelbaum has made a total of 4 transactions in Better Therapeutics Inc (BTTX) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Better Therapeutics Inc is the acquisition of 1,000 shares on December 20, 2021, which cost Kevin J Appelbaum around $4,600.

Insider Trading History of Kevin J Appelbaum

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kevin J Appelbaum Trading Performance

GuruFocus tracks the stock performance after each of Kevin J Appelbaum's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kevin J Appelbaum is -47.93%. GuruFocus also compares Kevin J Appelbaum's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kevin J Appelbaum within 3 months outperforms 0 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Kevin J Appelbaum's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Kevin J Appelbaum

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -14.85 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -15.34 LIMIT LIMIT LIMIT LIMIT LIMIT

Kevin J Appelbaum Ownership Network

Ownership Network List of Kevin J Appelbaum

No Data

Ownership Network Relation of Kevin J Appelbaum

Insider Network Chart

Kevin J Appelbaum Owned Company Details

What does Better Therapeutics Inc do?

Who are the key executives at Better Therapeutics Inc?

Kevin J Appelbaum is the director & 10 percent owner & Chief Executive Officer of Better Therapeutics Inc. Other key executives at Better Therapeutics Inc include director & See Remarks Frank Karbe , director & 10 percent owner & See Remarks David P Perry , and Chief Medical Officer Mark A. Berman .

Better Therapeutics Inc (BTTX) Insider Trades Summary

Over the past 18 months, Kevin J Appelbaum made no insider transaction in Better Therapeutics Inc (BTTX). Other recent insider transactions involving Better Therapeutics Inc (BTTX) include a net purchase of 34,851 shares made by Elder Granger , a net purchase of 1,233,045 shares made by David P Perry , and a net purchase of 685,025 shares made by Geoffrey M. Parker .

In summary, during the past 3 months, insiders sold 0 shares of Better Therapeutics Inc (BTTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Better Therapeutics Inc (BTTX) were sold and 2,418,738 shares were bought by its insiders, resulting in a net purchase of 2,418,738 shares.

Better Therapeutics Inc (BTTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Better Therapeutics Inc Insider Transactions

No Available Data

Kevin J Appelbaum Mailing Address

Above is the net worth, insider trading, and ownership report for Kevin J Appelbaum. You might contact Kevin J Appelbaum via mailing address: 4160 Dublin Blvd., Suite 200, Dublin Ca 94568.